TD Private Client Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4K | Buy |
338
+326
| +2,717% | +$40.9K | ﹤0.01% | 872 |
|
|
2025
Q1 | $1.64K | Sell |
12
-40
| -77% | -$5.47K | ﹤0.01% | 1218 |
|
|
2024
Q4 | $7.95K | Sell |
52
-333
| -86% | -$50.9K | ﹤0.01% | 1068 |
|
|
2024
Q3 | $74.6K | Buy |
385
+77
| +25% | +$14.9K | ﹤0.01% | 765 |
|
|
2024
Q2 | $71.4K | Sell |
308
-28
| -8% | -$6.49K | ﹤0.01% | 740 |
|
|
2024
Q1 | $72.5K | Sell |
336
-2,797
| -89% | -$603K | ﹤0.01% | 749 |
|
|
2023
Q4 | $811K | Sell |
3,133
-294
| -9% | -$76.1K | 0.03% | 362 |
|
|
2023
Q3 | $881K | Sell |
3,427
-961
| -22% | -$247K | 0.04% | 329 |
|
|
2023
Q2 | $1.25M | Sell |
4,388
-289
| -6% | -$82.3K | 0.05% | 297 |
|
|
2023
Q1 | $1.3M | Sell |
4,677
-210
| -4% | -$58.4K | 0.06% | 284 |
|
|
2022
Q4 | $1.35M | Sell |
4,887
-818
| -14% | -$227K | 0.06% | 271 |
|
|
2022
Q3 | $1.52M | Sell |
5,705
-47
| -0.8% | -$12.5K | 0.08% | 240 |
|
|
2022
Q2 | $1.17M | Buy |
5,752
+724
| +14% | +$148K | 0.06% | 290 |
|
|
2022
Q1 | $1.06M | Buy |
5,028
+4,773
| +1,872% | +$1.01M | 0.05% | 328 |
|
|
2021
Q4 | $61.2K | Sell |
255
-63
| -20% | -$15.1K | ﹤0.01% | 715 |
|
|
2021
Q3 | $90K | Sell |
318
-24
| -7% | -$6.79K | ﹤0.01% | 643 |
|
|
2021
Q2 | $118K | Buy |
342
+24
| +8% | +$8.31K | 0.01% | 595 |
|
|
2021
Q1 | $89K | Buy |
318
+28
| +10% | +$7.83K | ﹤0.01% | 617 |
|
|
2020
Q4 | $71K | Sell |
290
-113
| -28% | -$27.7K | ﹤0.01% | 606 |
|
|
2020
Q3 | $114K | Sell |
403
-287
| -42% | -$81.4K | 0.01% | 516 |
|
|
2020
Q2 | $185K | Sell |
690
-131
| -16% | -$35K | 0.01% | 460 |
|
|
2020
Q1 | $260K | Sell |
821
-1,999
| -71% | -$632K | 0.02% | 391 |
|
|
2019
Q4 | $837K | Buy |
+2,820
| New | +$837K | 0.05% | 285 |
|